Logo image of CLMT

CALUMET INC (CLMT) Stock Fundamental Analysis

NASDAQ:CLMT - US1314281049 - Common Stock

16.33 USD
+0.15 (+0.93%)
Last: 8/28/2025, 8:01:11 PM
16.33 USD
0 (0%)
After Hours: 8/28/2025, 8:01:11 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CLMT. CLMT was compared to 208 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of CLMT have multiple concerns. CLMT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CLMT has reported negative net income.
CLMT had a negative operating cash flow in the past year.
CLMT had negative earnings in 4 of the past 5 years.
In multiple years CLMT reported negative operating cash flow during the last 5 years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -16.25%, CLMT is not doing good in the industry: 89.42% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -16.25%
ROE N/A
ROIC N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

CLMT's Operating Margin has declined in the last couple of years.
The Profit Margin and Operating Margin and Gross Margin are not available for CLMT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

More info and screens

0

2. Health

2.1 Basic Checks

CLMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CLMT has more shares outstanding
CLMT has more shares outstanding than it did 5 years ago.
CLMT has a worse debt/assets ratio than last year.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 0.35, we must say that CLMT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CLMT (0.35) is worse than 65.87% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACCN/A
WACC10.97%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 0.76 indicates that CLMT may have some problems paying its short term obligations.
CLMT has a worse Current ratio (0.76) than 72.60% of its industry peers.
A Quick Ratio of 0.45 indicates that CLMT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.45, CLMT is doing worse than 87.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.45
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for CLMT have decreased strongly by -1756.25% in the last year.
Looking at the last year, CLMT shows a very negative growth in Revenue. The Revenue has decreased by -22.79% in the last year.
CLMT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.94% yearly.
EPS 1Y (TTM)-1756.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-254.17%
Revenue 1Y (TTM)-22.79%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-9.45%

3.2 Future

The Earnings Per Share is expected to grow by 29.17% on average over the next years. This is a very strong growth
Based on estimates for the next years, CLMT will show a small growth in Revenue. The Revenue will grow by 7.25% on average per year.
EPS Next Y-57.35%
EPS Next 2Y42%
EPS Next 3Y21.71%
EPS Next 5Y29.17%
Revenue Next Year1.05%
Revenue Next 2Y1.53%
Revenue Next 3Y6.59%
Revenue Next 5Y7.25%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLMT. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 375.82 indicates a quite expensive valuation of CLMT.
CLMT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CLMT is more expensive than 70.19% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.78, CLMT is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 375.82
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

A more expensive valuation may be justified as CLMT's earnings are expected to grow with 21.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42%
EPS Next 3Y21.71%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLMT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALUMET INC

NASDAQ:CLMT (8/28/2025, 8:01:11 PM)

After market: 16.33 0 (0%)

16.33

+0.15 (+0.93%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners47.37%
Inst Owner Change10.62%
Ins Owners2.94%
Ins Owner Change-0.04%
Market Cap1.42B
Analysts78.33
Price Target20.46 (25.29%)
Short Float %14.31%
Short Ratio9.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-377.07%
Min EPS beat(2)-407.62%
Max EPS beat(2)-346.52%
EPS beat(4)1
Avg EPS beat(4)-194.87%
Min EPS beat(4)-407.62%
Max EPS beat(4)30.36%
EPS beat(8)4
Avg EPS beat(8)85.48%
EPS beat(12)5
Avg EPS beat(12)-504.19%
EPS beat(16)6
Avg EPS beat(16)-374.79%
Revenue beat(2)2
Avg Revenue beat(2)9.05%
Min Revenue beat(2)8.78%
Max Revenue beat(2)9.31%
Revenue beat(4)4
Avg Revenue beat(4)7.51%
Min Revenue beat(4)0.99%
Max Revenue beat(4)10.98%
Revenue beat(8)8
Avg Revenue beat(8)8.83%
Revenue beat(12)11
Avg Revenue beat(12)8.29%
Revenue beat(16)15
Avg Revenue beat(16)10.55%
PT rev (1m)0.31%
PT rev (3m)-2.13%
EPS NQ rev (1m)-47.8%
EPS NQ rev (3m)-2482%
EPS NY rev (1m)-57.24%
EPS NY rev (3m)-222.79%
Revenue NQ rev (1m)12.38%
Revenue NQ rev (3m)10.51%
Revenue NY rev (1m)5.04%
Revenue NY rev (3m)11.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 375.82
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.94
EYN/A
EPS(NY)0.04
Fwd EY0.27%
FCF(TTM)-2.3
FCFYN/A
OCF(TTM)-1.46
OCFYN/A
SpS46.92
BVpS-11.64
TBVpS-11.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.25%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.9%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 48.93%
Cap/Sales 1.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.45
Altman-Z 0.35
F-Score2
WACC10.97%
ROIC/WACCN/A
Cap/Depr(3y)260.7%
Cap/Depr(5y)180.19%
Cap/Sales(3y)6.59%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1756.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-254.17%
EPS Next Y-57.35%
EPS Next 2Y42%
EPS Next 3Y21.71%
EPS Next 5Y29.17%
Revenue 1Y (TTM)-22.79%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-9.45%
Revenue Next Year1.05%
Revenue Next 2Y1.53%
Revenue Next 3Y6.59%
Revenue Next 5Y7.25%
EBIT growth 1Y-186.36%
EBIT growth 3YN/A
EBIT growth 5Y-39.24%
EBIT Next Year2958.15%
EBIT Next 3Y283.25%
EBIT Next 5Y146.58%
FCF growth 1Y66.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-227.06%
OCF growth 3YN/A
OCF growth 5YN/A